Clinical Trials Logo

Coronary Artery Disease clinical trials

View clinical trials related to Coronary Artery Disease.

Filter by:

NCT ID: NCT00694005 Completed - Clinical trials for Coronary Artery Disease

Choice Of Optimal Strategy For Bifurcation Lesions With Normal Side Branch

CROSS
Start date: January 2008
Phase: Phase 4
Study type: Interventional

Few data are available about the late patency of side branches in association with the currently used stent types and implantation techniques.

NCT ID: NCT00693758 Completed - Myocardial Ischemia Clinical Trials

Assessment of Oxygen Changes in the Heart With Cardio-vascular Magnetic Resonance Imaging

Start date: January 2006
Phase: Phase 0
Study type: Interventional

The ability of a new SSFP-based BOLD MRI sequence to assess myocardial oxygenation changes in response to coronary flow changes induced by adenosine and increased CO2-partial pressure will be examined in healthy volunteers and patients with suspected coronary artery disease. Also the susceptibility of a new SSFP-based BOLD sensitive MRI sequence to changes in arterial oxygenation will be examined. This will help understand the physiologic basis of oxygen sensitive imaging of the heart.

NCT ID: NCT00693589 Completed - Clinical trials for Cardiovascular Disease

Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Endothelium-Dependent Vasodilatation of Forearm Resistance Vessels in Patients With Coronary Heart Disease

Start date: January 2005
Phase: Phase 2
Study type: Interventional

Endothelial dysfunction is an early marker of atherosclerosis and is found in patients (pts) with coronary (CAD) and peripheral artery disease (PAD). Statin-therapy has been shown to improve endothelial function in pts with CAD or PAD by reducing LDL-cholesterol and inflammatory markers. B-group vitamin-supplements have variable been reported to have positive or neutral effects on endothelial function. Therefore, we want to compare the effect of rosuvastatin and B-group vitamin supplementation on endothelial function of the forearm resistance vessels in pts with cardiovascular disease.

NCT ID: NCT00693537 Completed - Clinical trials for Coronary Artery Disease

Exercise Training Improves Coronary Endothelial Dysfunction in Diabetes Mellitus Type 2 and Coronary Artery Disease

Start date: n/a
Phase: Phase 4
Study type: Interventional

Patients with type 2 diabetes mellitus suffer from accelerated coronary artery disease. We will assess the effects of exercise training on coronary endothelial function, vascular structure, and inflammation both in serum and skeletal muscle biopsies, as well as expression of diabetes candidate genes.

NCT ID: NCT00693251 Completed - Clinical trials for Coronary Artery Disease

Optimal Stenting Strategy For True Bifurcation Lesions

PERFECT
Start date: January 2008
Phase: Phase 4
Study type: Interventional

It is unclear which stenting strategy will be optimal for true bifurcation coronary lesions.

NCT ID: NCT00693069 Completed - Clinical trials for Coronary Artery Disease

Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function

Start date: September 2004
Phase: Phase 3
Study type: Interventional

Adequate platelet inhibition before percutaneous coronary intervention (PCI) reduces peri-procedural and long-term ischemic complications. Documented reduced response to clopidogrel has been associated with subsequent major adverse cardiovascular events. Strategies to optimize platelet inhibition pre-PCI are under investigation. This study sought to evaluate the effect on platelet aggregation of four different dosing regimens of clopidogrel given before elective PCI.

NCT ID: NCT00690209 Completed - Clinical trials for Ischemic Heart Disease

By Pass Surgery With Stem Cell Therapy in Chronic Ischemic Cardiopathy

Start date: May 2008
Phase: Phase 2
Study type: Interventional

Surgical revascularization has proven its efficacy in term of morbidity and mortality in patients with multivessel coronary disease and poor left ventricular function. Nevertheless, if left ventricle is severely dilated, the improvement of global contractility and reduction of volumes is frequently absent after CABG even if substantial amount of myocardial viability is present. A value of > 140 ml for end systolic volume has been proposed as the cut off for the absence of recovery after revascularization. Recently, a reduction of cardiac volumes and improvement of regional and global contractility has been demonstrated in patients with advanced ischemic heart disease, severe dilation of left ventricle and poor candidates for revascularization after injection of stem cells in territories with residual viability.

NCT ID: NCT00688532 Completed - Prostate Cancer Clinical Trials

Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not

Start date: December 2007
Phase: N/A
Study type: Observational

A retrospective cohort study performed in the GPRD,UK. All patients with incident prostate cancer identified between 1 Jan 1999 and 31 Dec 2005 and a frequency-matched cohort of the general population will be followed- up for two outcomes; CHD including acute myocardial infarction or death from coronary heart disease and HF until Dec 31, 2006. Outcomes will be validated through requests to primary care physicians. Incidence rate´ratios of CHD and HF in the two cohorts will be calculated. In the cohort of prostate cancer the relative risk of CHD and HF associated with the use of bicalutamide compared to non-use will be estimated.

NCT ID: NCT00686647 Completed - Clinical trials for Coronary Artery Disease

AngioSculpt® Coronary Bifurcation Study

AGILITY
Start date: April 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate a new angioplasty catheter, AngioSculpt® for the treatment of bifurcation lesions (blockages occurring at branch points) in coronary arteries.

NCT ID: NCT00685984 Completed - Myocardial Ischemia Clinical Trials

Peripheral Endothelial Function and Coronary Status in Asymptomatic Diabetic Patients

PEFDIA
Start date: January 2008
Phase: N/A
Study type: Observational

Silent myocardial ischemia is usual in type 2 diabetic patients and associated with coronary stenoses and endothelial dysfunction or both. We therefore hypothesized that peripheral endothelial dysfunction is a marker of silent myocardial ischemia. The aim of the study is, in 120 asymptomatic type 2 diabetic patients, to evaluate the relations between coronary status, assessed with myocardial scintigraphy and subsequent coronary angiography in case of abnormality, and peripheral endothelial function, according to post-occlusive hyperaemia endothelium-dependent brachial artery dilation.